Skip to main content

TCGX · TCGX Acquisition Corp. · Shareholders & Ownership

Track TCGX — free
$10.01 -0.01 (-0.10%) At close · Oct 20
Market Cap
$113.26M
Shares
11.30M
Volume · Oct 20 1.08M Avg daily vol (52 sessions) 124.3K

Every disclosed holder of TCGX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns TCGX

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 1,000,000 8.85%
Remaining 10,303,750 91.15%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 11,303,750, the issuer's latest cover-page count restated onto today's split basis.

Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of TCGX

# Holder Shares
1
BIOTECHNOLOGY VALUE FUND L P
13G CIK 918923 · Unknown · Aug 5, 2026
Rule 13d-1(c), passive investor
500,000
2
RA CAPITAL MANAGEMENT, L.P.
13G CIK 1346824 · Registered investment adviser · Aug 6, 2026
Rule 13d-1(c), passive investor
500,000
3
Yu Chen-Ming
Insider CIK 1517933 · Aug 6, 2026
Chief Executive Officer, 10% Owner, issuer-wide, not summed
436,250

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 2137965 CUSIP G8708J109 Visit website